Company Filing History:
3 out of 2,104 
1 out of 832,891 Years Active: 1999-2000
Title: The Innovative Contributions of Inventor Kurt Strand
Introduction: Kurt Strand, an accomplished inventor based in Issaquah, WA, has made significant contributions to the field of biomedical research. With a portfolio that includes four patents, his work primarily focuses on the intricacies of herpes viruses, specifically the RFHV/KSHV subfamily. This article explores his latest patents, career highlights, and collaborations with fellow innovators.
Latest Patents: One of Kurt Strand's latest patents revolves around the Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses. This invention pertains to polynucleotides encoding Glycoprotein B from gamma herpes viruses, which are characterized in detail. The DNA extracts used in his research were obtained from Macaque nemestrina and Macaque mulatta monkeys diagnosed with retroperitoneal fibromatosis (RF), as well as from human AIDS patients affected by Kaposi's sarcoma (KS). His research reveals that the nucleotide sequences of a specific 319 base pair fragment exhibit approximately 76% identity between RFHV1 and KSHV, while being 60-63% identical to the closest related gamma herpes viruses outside the RFHV/KSHV subfamily. Additionally, the protein sequences encoded within these fragments are around 91% identical between RFHV1 and KSHV. Notably, the full-length KSHV Glycoprotein B sequence contains a transmembrane domain near the N-terminus and a range of potentially antigenic sites in the extracellular domain. Kurt's patented methods allow for the characterization of Glycoprotein B encoding regions across the RFHV/KSHV subfamily, aiding in the diagnosis of infections and the elicitation of immune responses against Glycoprotein B.
Career Highlights: Kurt Strand has had a distinguished career, contributing to various research initiatives and projects. He has worked with notable institutions, including the University of Washington, where his skills and expertise have aided in advancing the understanding of herpes viruses within the scientific community.
Collaborations: Throughout his career, Kurt Strand has collaborated with esteemed individuals, such as Timothy M. Rose and Marnix L. Bosch. These collaborations have enriched his research and have been instrumental in the development of his patents.
Conclusion: Kurt Strand stands out as a significant inventor in the realm of biomedical innovation. His work on the Glycoprotein B of the RFHV/KSHV subfamily highlights his commitment to advancing scientific knowledge and improving diagnostic methods. As he continues to contribute to the field, his impact on biomedical research will undoubtedly be felt for years to come.